AzTrials
AzTrials

Functional IndependenceIMTNCT04686019

More Air - Better Performance - Faster Recovery

A study testing Inspiratory muscle training (IMT) in people with Functional Independence and Respiratory Insufficiency, run by Central Jutland Regional Hospital at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this study is to investigate i) the effect of 3 weeks IMT to adults post-stroke to maximal inspiratory pressure (MIP) and ii) the effects of 3 weeks IMT to the degree of dependency in activities of daily living, endurance in gait, fatigue, voice volume, phonation endurance, and expiratory function. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Inspiratory muscle training (IMT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteDenmark
Study dates
15 Apr 2021to 30 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First time brain infarction or brain haemorrhage 0-6 month.
  • Able to give written consent and being cognitive and communicative able to understand and participate in the maximal inspiration pressure test (MIP)
  • Reduced MIP below gender and age specific normal standard

Who cannot join

  • Diagnosis of myocardial infarction within the last 3 months
  • Significant pulmonary disease (severe COPD), saturation below 90 if having COPD for others saturation below 92
  • Neurological deficits other than stroke
  • Facial palsy that affects proper labial occlusion
  • Dizziness or nausea/vomiting during MIP-testing.

Trial locations and contacts

1 site in 1 country.

Hanne Pallesen, Post Doc contact

004523821365

hannpall@rm.dk

Simon S Kjeldsen, PhD student contact

simokjel@rm.dk

Denmark1 site, 1 recruiting
  • Regional Hospital Hammel Neurocenter

    Hammel, 8450

    Hanne Pallesen, post doc, +4523821365, hannpall@rm.dk

    Simon S Kjeldsen, post doc, simokjel@rm.dk

    Recruiting

Other trials in Denmark

About this study

Official title: "More Air - Better Performance - Faster Recovery": Study Protocol for a Randomised Controlled Trial of the Effect of Inspiratory Muscle Training for Adults Post-stroke

The objective of this study is to investigate i) the effect of 3 weeks IMT to adults post-stroke to maximal inspiratory pressure (MIP) and ii) the effects of 3 weeks IMT to the degree of dependency in activities of daily living, endurance in gait, fatigue, voice volume, phonation endurance, and expiratory function.

Methods/Design: Randomised controlled trial (RCT) comparing IMT to conventional neurorehabilitation (usual practise). 80 patients, with reduced maximal inspiration pressure (MIP) hospitalized at a specialized neurorehabilitation hospital in Denmark will be included.

Read the detailed description

Background: Stroke results in varying disabilities physical, cognitive, emotional and/or social both in short term and long term. Motor impairments are significantly persistent consequences post-stroke among these are decreased respiratory muscle function, decreased ability to expand thorax and postural dysfunction. These deficits influence the patient's ability in daily activities, fatigue, endurance and quality of life. Inspiratory muscle training (IMT) is training to improve the strength and endurance of diaphragm and the external intercostal muscles. The objective of this study is to investigate i) the effect of 3 weeks IMT to adults post-stroke to maximal inspiratory pressure (MIP) and ii) the effects of 3 weeks IMT to the degree of dependency in activities of daily living, endurance in gait, fatigue, voice volume, phonation endurance, and expiratory function.

Methods/Design: Randomised controlled trial (RCT) comparing IMT to conventional neurorehabilitation (usual practise). 80 patients, with reduced maximal inspiration pressure (MIP) hospitalized at a specialized neurorehabilitation hospital in Denmark will be included. The intervention group will add-on IMT sessions exercising at 30 % of MIP. Patients in the intervention group perform 2 sessions a day (One session of IMT with IMT threshold flute consists of 2 times 15 inspirations in normal breathing rhythm (5-10 min)), 7 days a week for 3 weeks. Training can be with or without supervision of physiotherapist.

Being tested
Inspiratory muscle training (IMT)
Keywords
Stroke,, Functioning, Fatigue, Voice volume
Medical subject headings
Respiratory Insufficiency, Stroke, Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Inspiratory muscle training (IMT)Other

    IMT and conventional neurorehabilitation - treatment as usual. The intervention group will add-on IMT sessions exercising at 30 % of MIP. MIP is measured by instructing the patient to perform five forceful inspirations against an occluded mouthpiece (Power Breath). The best score is multiplied by 0.3 to determine the resistance. IMT is performed with IMT Threshold flute with the calculated resistance. During the measurement with Power Breath the patient sits straight up and uses nose clip. The patient can receive help to hold the Power Breath if necessary.

    One session of IMT with IMT threshold flute consists of 2 times 15 inspirations in normal breathing rhythm (5-10 min). Patients in the intervention group perform 2 sessions a day (morning and evening), training is performed prior to a meal, 7 days a week for 3 weeks.

Study groups in NCT04686019
Study groupRoleWhat they receive
Intervention groupExperimental* 2 x IMT (5-10 min) 2 times a day 7 days a week for 3 weeks with or without supervision * Log-book * Conventional neurorehabilitation
Receives: Other: Inspiratory muscle training (IMT)
Control groupActive comparatorConventional neurorehabilitation
Receives: Other: Inspiratory muscle training (IMT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal inspiratory pressure (MIP)

    Change of MIP assess with the Power Breath. This is an objective measurement to describe the inspiratory capacity. Age specific

    Measured: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention

Secondary outcomes (5)
  1. Functional Independence Measure (FIM) - both total score ( range from 18 to 126, with higher scores indicating more independence) and motor sub score (max 91)

    to assess the degree of changed dependency in daily activities

    Measured: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention

  2. Fatigue Severity Scale (FSS)

    to measure change of fatigue (1-63) higher scores indicating more fatigue affected.

    Measured: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention

  3. 6-minutes walking test

    to measure change of endurance

    Measured: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention

  4. Voice volume

    to measure change of voice volume by recording of an a-sound with the App Voice Analyst and to measure Phonation endurance (how long the a-sound last)

    Measured: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention

  5. Expiratory function

    To measure change of Peak expiratory flow (PEF), Forced expiratory volume in 1 second (FEV1), Forced vital capacity (FVC) and FEV1/FVC ratio will be assessed with a peak flow meter (Spirometry device Micro 6300)

    Measured: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2020
  2. Study start15 Apr 2021
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion30 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04686019
Sponsor's protocol ID
1-16-02-279-20
Acronym
IMT
Status last verified
Oct 2020
First submitted
28 Oct 2020
Last updated
30 Aug 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: no plan

Publications

  • Sorensen SL, Kjeldsen SS, Mortensen SS, Hansen UT, Hansen D, Pedersen AR, Pallesen H. "More air-better performance-faster recovery": study protocol for randomised controlled trial of the effect of post-stroke inspiratory muscle training for adults. Trials. 2021 Aug 28;22(1):575. doi: 10.1186/s13063-021-05551-8.

    PubMed 34454573

Questions about this trial

What is this clinical trial studying?

A study testing Inspiratory muscle training (IMT) in people with Functional Independence and Respiratory Insufficiency, run by Central Jutland Regional Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hanne Pallesen, Post Doc (004523821365, hannpall@rm.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal inspiratory pressure (MIP) (time frame: Assessed 0-4 days before intervention, 0-4 days after ended intervention assessment and 3 months after ended intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04686019, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in